Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy
NCT01452113
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
Vildagliptin
Sponsor
University Hospital, Toulouse
Collaborators
[object Object]
[object Object]
[object Object]